COMPLETEDNA

Is Adipose Tissue a Reservoir for SARS-Cov2 Spread in Covid-19 Patients?

Is Adipose Tissue a Reservoir for SARS-Cov2 Spread?

NCT04427878•Centre Hospitalier Universitaire de Nice

Summary

Resident cells of human adipose tissue express ACE2 and DPP4, receptors for SARS-Cov2. The hypothesis is that the virus may enter and spread in fat depots.

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Male or female ≥ 18 years old
•Patients testing positive for Covid19
•Patients affiliated to social security
•Signing of free and informed consent

Exclusion Criteria

•Vulnerable persons (- minors,
•adults under guardianship or curatorship,
•pregnant women,
•persons deprived of their liberty,
•persons who do not master the French language)

Locations (1)

CHU de Nice

Nice, France

Key Dates

Start Date

August 3, 2020

Primary Completion Date

September 9, 2020

Completion Date

September 9, 2020

Last Updated

June 27, 2024

Enrollment

5

ACTUAL participants

Conditions

Covid-19 Patients

Interventions

biopsies of subcutaneous adipose tissue

PROCEDURE

Potential Role of Inflammasome NLRP3 And IL-1B Gene Expression in COVID-19 Patients: Impact of Ferretin and D -Dimer.

NCT06080750

Inflammasome NLRP3 And IL-1B Gene Expression in COVID-19 Patients

View study

COMPLETEDPHASE3

Aerosolized Versus Intravenous Colistin-based Antimicrobial Regimens in Hospitalized COVID-19 Patients With Bacterial Coinfection: A Randomized Controlled Trial

NCT05689229

Secondary Bacterial Infection in COVID-19 Patients

View study

COMPLETEDNA

Awake Prone Positioning in COVID-19 Suspects With Hypoxemic Respiratory Failure

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: June 27, 2024Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

NCT04853979

COVID-19 PatientsHypoxemic Respiratory Failure+1 more

View study

UNKNOWNPHASE1

To Evaluate the Safety, Tolerability and Pharmacokinetic Properties of DWRX2003

NCT04592835

COVID-19 Patients

View study

UNKNOWNPHASE2

Role of Co-trimoxazole in Severe COVID-19 Patients

NCT04470531

Covid19Severe COVID-19 Patients

View study